61
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Phenotypes, Lung Microbiota and Cytokine Responses in Pneumonia After Hematopoietic Stem Cell Transplantation

, , , ORCID Icon &
Pages 6055-6065 | Published online: 19 Nov 2021

References

  • Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med. 2006;354(17):1813–1826. doi:10.1056/NEJMra052638
  • Gooley TA, Chien JW, Pergam SA, et al. Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med. 2010;363(22):2091–2101. doi:10.1056/NEJMoa1004383
  • Lucena CM, Torres A, Rovira M, et al. Pulmonary complications in hematopoietic SCT: a prospective study. Bone Marrow Transplant. 2014;49(10):1293–1299. doi:10.1038/bmt.2014.151
  • Aguilar-Guisado M, Jimenez-Jambrina M, Espigado I, et al. Pneumonia in allogeneic stem cell transplantation recipients: a multicenter prospective study. Clin Transplant. 2011;25(6):E629–38. doi:10.1111/j.1399-0012.2011.01495.x
  • Ljungman P, Ward KN, Crooks BN, et al. Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 2001;28(5):479–484. doi:10.1038/sj.bmt.1703139
  • Ljungman P, de la Camara R, Perez-Bercoff L, et al. Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipients. Haematologica. 2011;96(8):1231–1235. doi:10.3324/haematol.2011.041913
  • Ljungman P. Respiratory virus infections in bone marrow transplant recipients: the European perspective. Am J Med. 1997;102(3A):44–47. doi:10.1016/s0002-9343(97)00010-7
  • Harrington RD, Hooton TM, Hackman RC, et al. An outbreak of respiratory syncytial virus in a bone marrow transplant center. J Infect Dis. 1992;165(6):987–993. doi:10.1093/infdis/165.6.987
  • Ebbert JO, Limper AH. Respiratory syncytial virus pneumonitis in immunocompromised adults: clinical features and outcome. Respiration. 2005;72(3):263–269. doi:10.1159/000085367
  • Shen J, Hu Y, Zhao H, et al. Risk factors of non-invasive ventilation failure in hematopoietic stem-cell transplantation patients with acute respiratory distress syndrome. Ther Adv Respir Dis. 2020;14:1753466620914220. doi:10.1177/1753466620914220
  • Wohlfarth P, Beutel G, Lebiedz P, et al. Characteristics and outcome of patients after allogeneic hematopoietic stem cell transplantation treated with extracorporeal membrane oxygenation for acute respiratory distress syndrome. Crit Care Med. 2017;45(5):e500–e507. doi:10.1097/CCM.0000000000002293
  • Calfee CS, Delucchi K, Parsons PE, et al. Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials. Lancet Respir Med. 2014;2(8):611–620. doi:10.1016/S2213-2600(14)70097-9
  • Bos LD, Schouten LR, van Vught LA, et al. Identification and validation of distinct biological phenotypes in patients with acute respiratory distress syndrome by cluster analysis. Thorax. 2017;72(10):876–883. doi:10.1136/thoraxjnl-2016-209719
  • Calfee CS, Delucchi KL, Sinha P, et al. Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial. Lancet Respir Med. 2018;6(9):691–698. doi:10.1016/S2213-2600(18)30177-2
  • Herivaux A, Willis JR, Mercier T, et al. Lung microbiota predict invasive pulmonary aspergillosis and its outcome in immunocompromised patients. Thorax. 2021:thoraxjnl-2020-216179. doi:10.1136/thoraxjnl-2020-216179
  • O’Dwyer DN, Zhou X, Wilke CA, et al. Lung dysbiosis, inflammation, and injury in hematopoietic cell transplantation. Am J Respir Crit Care Med. 2018;198(10):1312–1321. doi:10.1164/rccm.201712-2456OC
  • Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(Suppl 2):S27–72. doi:10.1086/511159
  • Woodhead M. New guidelines for the management of adult lower respiratory tract infections. Eur Respir J. 2011;38(6):1250–1251. doi:10.1183/09031936.00105211
  • Chen H, Yin Y, Gao H, et al. Clinical utility of in-house metagenomic next-generation sequencing for the diagnosis of lower respiratory tract infections and analysis of the host immune response. Clin Infect Dis. 2020;71(Suppl 4):S416–S426. doi:10.1093/cid/ciaa1516
  • Franzosa EA, McIver LJ, Rahnavard G, et al. Species-level functional profiling of metagenomes and metatranscriptomes. Nat Methods. 2018;15(11):962–968. doi:10.1038/s41592-018-0176-y
  • Wood DE, Salzberg SL. Kraken: ultrafast metagenomic sequence classification using exact alignments. Genome Biol. 2014;15(3):R46. doi:10.1186/gb-2014-15-3-r46
  • Lu JBF, Thielen P, Salzberg SL. Bracken: estimating species abundance in metagenomics data. PeerJ Comput Sci. 2017;2017(1):e104. doi:10.7717/peerj-cs.104
  • Liu YX, Qin Y, Chen T, et al. A practical guide to amplicon and metagenomic analysis of microbiome data. Protein Cell. 2021;12(5):315–330. doi:10.1007/s13238-020-00724-8
  • Hamzic N, Tang Y, Eskilsson A, et al. Interleukin-6 primarily produced by non-hematopoietic cells mediates the lipopolysaccharide-induced febrile response. Brain Behav Immun. 2013;33:123–130. doi:10.1016/j.bbi.2013.06.006
  • Hubbard LL, Ballinger MN, Wilke CA, Moore BB. Comparison of conditioning regimens for alveolar macrophage reconstitution and innate immune function post bone marrow transplant. Exp Lung Res. 2008;34(5):263–275. doi:10.1080/01902140802022518
  • Zhou X, Loomis-King H, Gurczynski SJ, et al. Bone marrow transplantation alters lung antigen-presenting cells to promote TH17 response and the development of pneumonitis and fibrosis following gammaherpesvirus infection. Mucosal Immunol. 2016;9(3):610–620. doi:10.1038/mi.2015.85
  • Fan Y, Zhang G, Vong CT, Ye RD. Serum amyloid A3 confers protection against acute lung injury in Pseudomonas aeruginosa-infected mice. Am J Physiol Lung Cell Mol Physiol. 2020;318(2):L314–L322. doi:10.1152/ajplung.00309.2019
  • Percopo CM, Ma M, Brenner TA, et al. Critical adverse impact of IL-6 in acute pneumovirus infection. J Immunol. 2019;202(3):871–882. doi:10.4049/jimmunol.1800927
  • Savale L, Tu L, Rideau D, et al. Impact of interleukin-6 on hypoxia-induced pulmonary hypertension and lung inflammation in mice. Respir Res. 2009;10:6. doi:10.1186/1465-9921-10-6
  • Yadav H, Nolan ME, Bohman JK, et al. Epidemiology of acute respiratory distress syndrome following hematopoietic stem cell transplantation. Crit Care Med. 2016;44(6):1082–1090. doi:10.1097/CCM.0000000000001617
  • Iskander KN, Osuchowski MF, Stearns-Kurosawa DJ, et al. Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding. Physiol Rev. 2013;93(3):1247–1288. doi:10.1152/physrev.00037.2012
  • Denham W, Norman J. The potential role of therapeutic cytokine manipulation in acute pancreatitis. Surg Clin North Am. 1999;79(4):767–781. doi:10.1016/s0039-6109(05)70042-6
  • Huang L, Zhao X, Qi Y, et al. Sepsis-associated severe interleukin-6 storm in critical coronavirus disease 2019. Cell Mol Immunol. 2020;17(10):1092–1094. doi:10.1038/s41423-020-00522-6
  • Meynaar IA, Droog W, Batstra M, Vreede R, Herbrink P. In critically ill patients, serum procalcitonin is more useful in differentiating between sepsis and SIRS than CRP, Il-6, or LBP. Crit Care Res Pract. 2011;2011:594645. doi:10.1155/2011/594645
  • Burgmeijer EH, Duijkers R, Lutter R, Bonten MJM, Schweitzer VA, Boersma WG. Plasma cytokine profile on admission related to aetiology in community-acquired pneumonia. Clin Respir J. 2019;13(10):605–613. doi:10.1111/crj.13062
  • Siljan WW, Holter JC, Nymo SH, et al. Cytokine responses, microbial aetiology and short-term outcome in community-acquired pneumonia. Eur J Clin Invest. 2018;48(1):e12865. doi:10.1111/eci.12865
  • Doring M, Cabanillas Stanchi KM, Mezger M, et al. Cytokine serum levels during post-transplant adverse events in 61 pediatric patients after hematopoietic stem cell transplantation. BMC Cancer. 2015;15:607. doi:10.1186/s12885-015-1616-z
  • Wang J, Jiang M, Chen X, Montaner LJ. Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts. J Leukoc Biol. 2020;108(1):17–41. doi:10.1002/JLB.3COVR0520-272R
  • Gao R, Bhatnagar J, Blau DM, et al. Cytokine and chemokine profiles in lung tissues from fatal cases of 2009 pandemic influenza A (H1N1): role of the host immune response in pathogenesis. Am J Pathol. 2013;183(4):1258–1268. doi:10.1016/j.ajpath.2013.06.023
  • Voiriot G, Razazi K, Amsellem V, et al. Interleukin-6 displays lung anti-inflammatory properties and exerts protective hemodynamic effects in a double-hit murine acute lung injury. Respir Res. 2017;18(1):64. doi:10.1186/s12931-017-0553-6
  • Bhargava R, Janssen W, Altmann C, et al. Intratracheal IL-6 protects against lung inflammation in direct, but not indirect, causes of acute lung injury in mice. PLoS One. 2013;8(5):e61405. doi:10.1371/journal.pone.0061405
  • Yang ML, Wang CT, Yang SJ, et al. IL-6 ameliorates acute lung injury in influenza virus infection. Sci Rep. 2017;7:43829. doi:10.1038/srep43829
  • Dienz O, Rud JG, Eaton SM, et al. Essential role of IL-6 in protection against H1N1 influenza virus by promoting neutrophil survival in the lung. Mucosal Immunol. 2012;5(3):258–266. doi:10.1038/mi.2012.2
  • Murphy EA, Davis JM, Brown AS, Carmichael MD, Ghaffar A, Mayer EP. Effect of IL-6 deficiency on susceptibility to HSV-1 respiratory infection and intrinsic macrophage antiviral resistance. J Interferon Cytokine Res. 2008;28(10):589–595. doi:10.1089/jir.2007.0103
  • Ibrahim YF, Moussa RA, Bayoumi AMA, Ahmed AF. Tocilizumab attenuates acute lung and kidney injuries and improves survival in a rat model of sepsis via down-regulation of NF-kappaB/JNK: a possible role of P-glycoprotein. Inflammopharmacology. 2020;28(1):215–230. doi:10.1007/s10787-019-00628-y
  • Investigators R-C, Gordon AC, Mouncey PR, et al. Interleukin-6 receptor antagonists in critically ill patients with Covid-19. N Engl J Med. 2021;384(16):1491–1502. doi:10.1056/NEJMoa2100433
  • McGonagle D, Sharif K, O’Regan A, Bridgewood C. The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease. Autoimmun Rev. 2020;19(6):102537. doi:10.1016/j.autrev.2020.102537
  • Hotchkiss RS, Monneret G, Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol. 2013;13(12):862–874. doi:10.1038/nri3552